Gene · 2913
NIH grants1,644
NIH grants whose papers are about the gene, through NIH's grant-paper links.
281 to 300 of 1,644
Download this page as JSON| Grant | Title | GRM3 papers | Newest fiscal year |
|---|---|---|---|
| R01AG063175 | Modeling Alzheimer's disease genetic variants in hiPSC | 1 | 2023 |
| R01AG064656 | Targeting Histone K4 Methylation for Treatment of Alzheimer's Disease and Related Dementia | 1 | 2023 |
| R01CA227149 | Regulation of Amino-acid Transport in Human Gliomas | 1 | 2023 |
| R01CA239716 | Study of Interleukin 33 as a new immunotherapy of lung cancer | 1 | 2023 |
| R01GM089753 | New Computational Methods for Data-driven Protein Structure Prediction | 1 | 2023 |
| R01MH043784 | Prefrontal microcircuitry and cognition in schizophrenia | 1 | 2023 |
| R01MH051399 | Pharmacological Actions of Stress and Antidepressants | 1 | 2023 |
| R01MH116281 | Integrating epigenomics with DNA breathing dynamics for human non-coding disease variants | 1 | 2023 |
| R01NS065926 | Translation Control of Pain Plasticity | 1 | 2023 |
| R01NS082730 | Tau Conformation in Tauopathies and Neuronal Function | 1 | 2023 |
| R21MH130843 | Patterning human forebrain organoids by engineering controlled biochemical microenvironment | 1 | 2023 |
| R21NS126779 | New Tools for Studying Receptor Dimers | 1 | 2023 |
| R61NS124923 | Targeting TRPC3 Channels for Epileptic Seizures | 1 | 2023 |
| RF1AG083090 | Role of kynurenic acid in higher cognitive deficits: Mechanism and treatment strategies | 1 | 2023 |
| SC1GM131929 | Investigating drug targets and improving drug delivery for anti-cancer treatment of osteosarcoma | 1 | 2023 |
| T32GM007347 | Medical Scientist Training Program | 1 | 2023 |
| T32GM062754 | Integrated Training in Pharmacological Sciences | 1 | 2023 |
| T32MH019929 | Neuroscience: From Channels to Behavior | 1 | 2023 |
| ZIADA000478 | Basic brain mechanisms underlying drug addiction, craving, and relapse | 1 | 2023 |
| ZIAHG000070 | Analysis of Dominant Megacolon: Another Hirschsprung Disease Model | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2913/grants?page=15